Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Does the prulifloxacin ECG study prove cardiac safety of the drug?

Literature DB >> 19995093

Does the prulifloxacin ECG study prove cardiac safety of the drug?

Marek Malik¹.

Abstract

Entities: Chemical

Mesh：

Substances：

Year: 2010 PMID： 19995093 DOI： 10.2165/11319780-000000000-00000

Source DB: PubMed Journal: Clin Drug Investig ISSN： 1173-2563 Impact factor: 2.859

× No keyword cloud information.

13 in total

1. Clinical evaluation of QT/QTc prolongation and proarrhythmic potential for nonantiarrhythmic drugs: the International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use E14 guideline.

Authors: Borje Darpo; Thierry Nebout; Philip T Sager
Journal: J Clin Pharmacol Date: 2006-05 Impact factor: 3.126

Review 2. Errors and misconceptions in ECG measurement used for the detection of drug induced QT interval prolongation.

Authors: Marek Malik
Journal: J Electrocardiol Date: 2004 Impact factor: 1.438

Review 3. Thorough QT Studies: Questions and Quandaries.

Authors: Marek Malik; Christine E Garnett; Joanne Zhang
Journal: Drug Saf Date: 2010-01-01 Impact factor: 5.606

4. Near-thorough QT study as part of a first-in-man study.

Authors: Marek Malik; Katerina Hnatkova; John Ford; David Madge
Journal: J Clin Pharmacol Date: 2008-08-29 Impact factor: 3.126

5. Effects of prulifloxacin on cardiac repolarization in healthy subjects: a randomized, crossover, double-blind versus placebo, moxifloxacin-controlled study.

Authors: Maria Teresa Rosignoli; Giorgio Di Loreto; Paolo Dionisio
Journal: Clin Drug Investig Date: 2010 Impact factor: 2.859

Review 6. Drug-induced torsades de pointes and implications for drug development.

Authors: Robert R Fenichel; Marek Malik; Charles Antzelevitch; Michael Sanguinetti; Dan M Roden; Silvia G Priori; Jeremy N Ruskin; Raymond J Lipicky; Louis R Cantilena
Journal: J Cardiovasc Electrophysiol Date: 2004-04

7. Electrocardiographic QTc changes due to moxifloxacin infusion.

Authors: Marek Malik; Katerina Hnatkova; Anna Schmidt; Peter Smetana
Journal: J Clin Pharmacol Date: 2009-06 Impact factor: 3.126

8. Cycle length dependence of human action potential duration in vivo. Effects of single extrastimuli, sudden sustained rate acceleration and deceleration, and different steady-state frequencies.

Authors: M R Franz; C D Swerdlow; L B Liem; J Schaefer
Journal: J Clin Invest Date: 1988-09 Impact factor: 14.808